The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. The federal outfit's "Commissioner's National Priority Voucher" (CNPV) program will include a "limited number of vouchers" for "companies aligned with U.S. national priorities," according to a June 17 press release.
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions align with the agency's national health priorities. www.statnews.com/2025/06/17/f ...
-- STAT (@statnews.com) Jun 17, 2025 at 12:15 PM
[image or embed]
Drudge Retort Headlines
Epstein Victims: Release the Files (89 comments)
Florida to Eliminate Vaccine Mandates (68 comments)
Alarm on Disney Vacations Amid Florida Anti-Vax Move (65 comments)
Xi: Our New Fighting Moves Are Unstoppable (45 comments)
A Spectacular Diplomatic Disaster (23 comments)
Trump, Running Scared, Disses Victims of His Pedo BFFs (20 comments)
Texas Freaks Out Over Lab-Grown Meat (18 comments)
US Manufacturing Contracts for Sixth Straight Month (12 comments)
Trump Asks Supreme Court to Save His Emergency Tariffs (11 comments)
Trump and Son's Stake in Crypto Grift Worth $5bn (10 comments)